Analysis of CXCL12 3'UTR G>A polymorphism in colorectal cancer

Oncol Rep. 2007 Dec;18(6):1583-7. doi: 10.3892/or.18.6.1583.

Abstract

Colorectal cancer is one of the most prevalent cancers in developed countries. However, the genetic factors influencing its appearance remain far from being fully characterized. Recently, a G>A functional transition mapping the 3' untranslated region of the CXCL12 gene (rs1801157) has been found to be under-represented among rectal cancer patients when compared to colon cancer patients from a Swedish series. Here we present the results from an independent analysis of CXCL12 rs1801157 in a larger CRC series of Spanish origin in order to analyse the robustness of this association within a different European population. No significant difference was observed between controls and colon or rectal cancer patients. We were also unable to find a correlation between rs1801157 and different prognostic markers such as metastasis development or disease-free survival time. The epidemiologic data involving CXCL12 rs1801157 in colorectal cancer risk are discussed.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • 3' Untranslated Regions / genetics*
  • Adult
  • Aged
  • Aged, 80 and over
  • Chemokine CXCL12 / genetics*
  • Colonic Neoplasms / genetics
  • Colorectal Neoplasms / genetics*
  • Colorectal Neoplasms / mortality
  • Disease-Free Survival
  • Female
  • Genotype
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide*
  • Rectal Neoplasms / genetics
  • Reference Values
  • Survival Analysis

Substances

  • 3' Untranslated Regions
  • CXCL12 protein, human
  • Chemokine CXCL12